Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Patient dosing begins in phase III satraplatin trial for prostate cancer

Oct. 1, 2003

HuMax-EGFr tested in a new phase I/II trial in head and neck cancer

Sep. 30, 2003

Lorus and Cyclacel enter license agreement for NC-381

Sep. 29, 2003

Enhanced activity of novel paclitaxel analogues against drug-resistant breast cancer cells

Sep. 29, 2003

Clinical trials of MB-7133 begin in liver cancer

Sep. 26, 2003

GSK-3beta negatively regulates normal cardiac growth and systolic function in transgenic mice

Sep. 26, 2003

Good safety and PK profile emerges for CC-8490 in healthy volunteers

Sep. 25, 2003

New CDK inhibitors in BMS development pipeline

Sep. 25, 2003

New antiangiogenic agents and their use patented by EntreMed

Sep. 25, 2003

Takeda presents new GnRH antagonists for cancer, prostatic hypertrophy, etc.

Sep. 25, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...